Equities

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Novartis AG's net income fell -62.26% from 17.78bn to 6.71bn despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 34.01% to 35.11%.
Gross margin65.41%
Net profit margin13.27%
Operating margin16.12%
Return on assets4.92%
Return on equity9.19%
Return on investment6.14%
More ▼

Cash flow in USDView more

In 2016, Novartis AG increased its cash reserves by 49.91%, or 2.33bn. The company earned 11.48bn from its operations for a Cash Flow Margin of 23.24%. In addition the company used 3.44bn on investing activities and also paid 5.31bn in financing cash flows.
Cash flow per share5.07
Price/Cash flow per share17.95
Book value per share28.97
Tangible book value per share2.83
More ▼

Balance sheet in USDView more

Novartis AG has a Debt to Total Capital ratio of 30.40%, a higher figure than the previous year's 22.46%.
Current ratio1.01
Quick ratio0.751
Total debt/total equity0.4371
Total debt/total capital0.304
More ▼

Growth rates in USD

Year on year, growth in dividends per share marginally increased 0.25% while earnings per share excluding extraordinary items fell by -2.83%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.57%
Div growth rate (5 year)2.45%
Payout ratio (TTM)98.50%
EPS growth(5 years)-5.83
EPS (TTM) vs
TTM 1 year ago
-0.9237
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.